Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089

Endocrinology
K VanweeldenJ Welsh

Abstract

1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] and its synthetic analog EB1089 induce characteristic morphological features of apoptosis in MCF-7 cells in vitro that coincide with up-regulation of clusterin and cathepsin B, proteins associated with apoptosis in the mammary gland, and with down-regulation of Bcl-2, an antiapoptotic protein. To determine whether vitamin D3 compounds could mediate apoptosis of breast tumors in vivo, we treated nude mice carrying established MCF-7 xenografts with the low calcemic vitamin D3 analog EB1089 via daily injection or sustained release pellets for up to 5 weeks. The volume of tumors from mice treated with 45 pmol/day EB1089 was 4-fold lower than that of tumors from vehicle-treated control mice after 5 weeks. The reduced growth of tumors from EB1089-treated mice was associated with characteristic apoptotic morphology and a marked reduction in the proportion of epithelial cells to stroma. After 5 weeks of treatment with EB1089, MCF-7 tumors exhibited a 6-fold increase in DNA fragmentation (as measured by in situ end labeling) relative to that in control tumors. The enhanced rate of apoptosis in tumors from EB1089-treated mice was coupled to a 2-fold reduction in proliferation (as measured by expres...Continue Reading

Citations

Jan 27, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Belinda Byrne, JoEllen Welsh
Oct 19, 2006·Journal of Clinical Pathology·C PalmieriD Vigushin
May 17, 2011·Breast Cancer Research : BCR·A Heather EliassenSusan E Hankinson
Jul 31, 2013·Clinical Interventions in Aging·Dao-Jun GongQing-Qu Guo
Oct 3, 2013·Nutrients·Meis Moukayed, William B Grant
Dec 18, 2001·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·P BortmanM M Brentani
Nov 4, 2000·Expert Opinion on Investigational Drugs·A VerstuyfC Mathieu
Jan 16, 2009·Reproductive Sciences·Faustino R Pérez-LópezJavier Haya
Nov 24, 2006·Technology in Cancer Research & Treatment·Shiwu ZhangBaocun Sun
Jan 1, 2011·Cancers·Kenneth C ValkenburgBart O Williams
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Susanna MiettinenTimo Ylikomi
Dec 30, 2003·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Roberto Lin, John H White
Aug 14, 2002·The British Journal of Dermatology·J E Osborne, P E Hutchinson
Sep 16, 2004·Journal of Cellular Biochemistry·Daniela A CapiatiRicardo L Boland
Aug 6, 2000·Circulation Research·D J MantellA E Canfield
Aug 29, 2007·Acta Pharmacologica Sinica·JoEllen Welsh
Mar 20, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Joellen Welsh
Oct 8, 2008·International Journal of Cancer. Journal International Du Cancer·Sascha AbbasJakob Linseisen
Sep 24, 2005·Cell Death and Differentiation·B ShannanJ Reichrath
Dec 2, 2006·Nature Reviews. Drug Discovery·Nick Barker, Hans Clevers
Oct 16, 2018·Endocrine Reviews·Roger BouillonJohn Bilezikian
Jan 10, 2014·Endocrine·Daniel D Bikle
Apr 10, 2015·Pharmaceutical Biology·Marco GiammancoGaetano Leto
Jun 20, 2002·Journal of Pineal Research·Samuel CosEmilio J Sánchez-Barceló
Jun 28, 2017·Targeted Oncology·Roya TabatabaiAlain Mita
Sep 25, 2003·Breast Cancer Research and Treatment·K W ColstonL Binderup
Sep 21, 2016·Annals of the New York Academy of Sciences·Daniel D Bikle
Jan 10, 2002·Journal of Andrology·Tara C Polek, Nancy L Weigel
Dec 9, 2004·The American Journal of Clinical Nutrition·Joellen Welsh

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis